Can Semaglutide Give You Diarrhoea? What the Evidence Says

Why does semaglutide affect your gut in the first place?

Semaglutide is a GLP-1 receptor agonist. It works partly by slowing how quickly food leaves your stomach, and that same mechanism alters the pace and rhythm of your whole digestive tract. For some people, the gut speeds up rather than slows — producing loose stools or outright diarrhoea. For others, constipation is the dominant pattern. Both responses come from the same source: a medicine that genuinely changes how your gastrointestinal system processes food and fluid.

The timing tends to follow the dosing schedule. The reasons semaglutide can trigger loose stools are covered in more detail on a dedicated page, but the short version is that the GI effects are most noticeable in the first one to two weeks at any new dose, then usually ease. If you have just moved up a rung on your dosing schedule and your bowel habits have shifted, that is the most likely explanation.

Does semaglutide give everyone diarrhoea? No. If you want a closer look at how semaglutide diarrhea tends to present and why it affects some people more than others, that page goes into the detail. Individual responses vary considerably depending on diet, gut sensitivity, how quickly doses are increased, and whether hydration is kept up alongside treatment. Eating smaller meals, avoiding very fatty or very spicy food, and drinking plenty of water all help the adjustment phase pass more quickly. A question our prescribers hear regularly is whether changing injection day affects GI symptoms. In most cases the pattern is tied to the dose level, not the specific day of the week, though avoiding an injection the night before something important, like a long flight or an early morning meeting, is a sensible practical habit.

What is normal, and what is a warning sign?

Deciding whether to push through a side effect or treat it as a signal to pause is the real decision most people face. Loose stools for a few days after starting a new dose, accompanied by no other symptoms and settling on their own, fits the typical pattern described in the clinical literature and on the full Wegovy side effects overview.

The picture looks different when diarrhoea is severe, lasts more than a few days, or is accompanied by vomiting significant enough to prevent you keeping fluids down. At that point the concern shifts from bowel discomfort to dehydration. Semaglutide can reduce thirst signals alongside appetite, so it is possible to become meaningfully dehydrated without feeling as thirsty as you otherwise would. Signs to take seriously include dizziness on standing, very dark urine, a dry mouth that does not improve with drinking, or significantly reduced urine output.

A separate warning: severe abdominal pain that radiates toward the back, with or without vomiting, is not a typical diarrhoea symptom. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, and pain of that character needs same-day medical assessment, not waiting to see if it passes. The longer guide to Wegovy's health risks covers this in full alongside other less common concerns.

When to get medical help

Call your GP or NHS 111 if diarrhoea has lasted more than 48 hours without improving, you cannot keep fluids down, or you notice signs of dehydration such as lightheadedness or barely any urine. Go to A&E or call 999 if you develop severe and persistent abdominal pain, especially pain spreading to your back, or if you have a suspected allergic reaction (swelling of the face, lips or throat, difficulty breathing).

You should also contact whoever prescribed your treatment. At nume, prescribers are reachable seven days a week through priority aftercare, so if you started or increased your dose recently and symptoms are worrying you, reaching out is always the right call rather than guessing. You can contact our team here.

If your experience seems unexpected or more severe than the above, it can also be reported directly to the MHRA via the Yellow Card scheme. Patient reports help regulators build a clearer picture of how these medicines behave in the real world.

Practical steps and the consultation question

Most of the practical management of semaglutide-related diarrhoea comes down to a few unglamorous but effective habits: smaller portions, reduced fat intake during the adjustment window, consistent hydration (water, not just coffee), and avoiding alcohol, which compounds GI irritation. Oral rehydration sachets are worth keeping at home during dose-escalation periods, the same logic as preparing a first-aid kit you hope not to need.

The trickier question is whether to continue at the current dose or discuss a slower escalation with your prescriber. A temporary dose reduction to settle GI symptoms is a clinical decision, not a failure. Some people titrate more slowly than the standard schedule and still reach their maintenance dose without extended discomfort. More on managing frequency and severity is available if you want to read around the topic further before speaking to someone.

If you are considering semaglutide and wondering whether the side-effect profile makes it the right choice, the free consultation at nume covers exactly that conversation: our prescribers go through your health history, any existing gut conditions, and what the expected adjustment looks like for your situation. Semaglutide (Wegovy) and tirzepatide (Mounjaro) have overlapping but distinct GI profiles, and if you are specifically asking whether Wegovy gives you diarrhea and how likely that is, the treatment overview sets out the differences in plain terms. Understanding the NICE appraisal of Wegovy (TA875) is also useful context if you want to see how the evidence was weighed at a regulatory level, including the trial data on tolerability.